{
  "patient_details": {
    "name": "piyush",
    "age": 30,
    "gender": "Male",
    "symptoms": [
      "Hematuria",
      "Proteinuria",
      "Edema",
      "High blood pressure",
      "Flank pain",
      "Lower back pain",
      "Fatigue",
      "Changes in urine color",
      "Uremia",
      "Nausea",
      "Vomiting",
      "Loss of appetite"
    ],
    "duration": "2 years",
    "family_history": "No",
    "medications": "No",
    "previous_diagnoses": "no",
    "travel": "no",
    "allergies": "no",
    "other_conditions": "no"
  },
  "top_rare_diseases": [
    {
      "disease_name": "Chronic Kidney Disease (CKD)",
      "score": 0.92,
      "description": "A long-term condition where the kidneys gradually lose their function.",
      "overview": "CKD is characterized by a gradual loss of kidney function over time, leading to complications like hypertension, edema, and uremia.",
      "signs_symptoms": [
        "Hematuria",
        "Proteinuria",
        "Edema",
        "High blood pressure",
        "Flank pain",
        "Lower back pain",
        "Fatigue",
        "Changes in urine color",
        "Uremia",
        "Nausea",
        "Vomiting",
        "Loss of appetite"
      ],
      "clinical_significance": "CKD can progress to end-stage renal disease, requiring dialysis or transplant.",
      "causes": "Diabetes, hypertension, glomerulonephritis, polycystic kidney disease.",
      "related_disorders": [
        "Diabetic Nephropathy",
        "Hypertensive Nephrosclerosis",
        "Glomerulonephritis",
        "Polycystic Kidney Disease"
      ],
      "diagnosis": "Urine tests, blood tests, imaging, kidney biopsy.",
      "treatment": "Lifestyle modifications, medications (ACE inhibitors, ARBs), dialysis, transplant.",
      "clinical_trials": [
        "Investigation of Finerenone in CKD",
        "Study of SGLT2 Inhibitors in CKD"
      ],
      "key_aspects": [
        "Early detection",
        "Management of comorbidities",
        "Slowing disease progression"
      ]
    },
    {
      "disease_name": "Nephrotic Syndrome",
      "score": 0.88,
      "description": "A collection of symptoms due to kidney damage, particularly to the glomeruli.",
      "overview": "Characterized by severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema.",
      "signs_symptoms": [
        "Proteinuria",
        "Edema",
        "High blood pressure",
        "Fatigue",
        "Changes in urine color",
        "Loss of appetite",
        "Nausea",
        "Vomiting"
      ],
      "clinical_significance": "Increased risk of infections, thrombosis, and progression to CKD.",
      "causes": "Minimal Change Disease, FSGS, membranous nephropathy, lupus nephritis.",
      "related_disorders": [
        "Minimal Change Disease",
        "Focal Segmental Glomerulosclerosis (FSGS)",
        "Membranous Nephropathy",
        "Lupus Nephritis"
      ],
      "diagnosis": "Urine protein-to-creatinine ratio, blood tests, kidney biopsy.",
      "treatment": "Immunosuppressants, ACE inhibitors, statins, diuretics.",
      "clinical_trials": [
        "Trial of Rituximab in Nephrotic Syndrome",
        "Study of Sparsentan for FSGS"
      ],
      "key_aspects": [
        "Identifying underlying cause",
        "Immunosuppressive therapy",
        "Managing complications"
      ]
    },
    {
      "disease_name": "Glomerulonephritis",
      "score": 0.85,
      "description": "Inflammation of the glomeruli, the filtering units of the kidneys.",
      "overview": "Can be acute or chronic, leading to kidney dysfunction.",
      "signs_symptoms": [
        "Hematuria",
        "Proteinuria",
        "High blood pressure",
        "Edema",
        "Flank pain",
        "Lower back pain",
        "Fatigue",
        "Changes in urine color"
      ],
      "clinical_significance": "Can progress to CKD or end-stage renal disease.",
      "causes": "Post-infectious, IgA nephropathy, lupus, vasculitis.",
      "related_disorders": [
        "IgA Nephropathy",
        "Lupus Nephritis",
        "Post-Streptococcal GN",
        "Vasculitis"
      ],
      "diagnosis": "Urine analysis, blood tests, kidney biopsy.",
      "treatment": "Depends on type; may include immunosuppressants, antibiotics.",
      "clinical_trials": [
        "Study of Azathioprine in IgA Nephropathy",
        "Trial of IVIG for Infectious GN"
      ],
      "key_aspects": [
        "Prompt treatment of infections",
        "Immunosuppressive therapy",
        "Monitoring kidney function"
      ]
    },
    {
      "disease_name": "Membranous Nephropathy",
      "score": 0.82,
      "description": "An autoimmune disease causing thickening of kidney glomeruli membranes.",
      "overview": "Leading cause of nephrotic syndrome in adults, often idiopathic.",
      "signs_symptoms": [
        "Proteinuria",
        "Edema",
        "High blood pressure",
        "Fatigue",
        "Changes in urine color",
        "Loss of appetite",
        "Nausea",
        "Vomiting"
      ],
      "clinical_significance": "Risk of progression to CKD and thrombotic events.",
      "causes": "Autoimmune, infections, lupus, medications.",
      "related_disorders": [
        "Nephrotic Syndrome",
        "Lupus Nephritis",
        "FSGS",
        "Diabetic Nephropathy"
      ],
      "diagnosis": "Urine analysis, blood tests, kidney biopsy.",
      "treatment": "Immunosuppressants, anticoagulants, ACE inhibitors.",
      "clinical_trials": [
        "Trial of Tacrolimus in Membranous Nephropathy",
        "Study of Adjuvant Therapy"
      ],
      "key_aspects": [
        "Immunosuppressive therapy",
        "Thrombosis prevention",
        "Disease monitoring"
      ]
    },
    {
      "disease_name": "IgA Nephropathy (Berger's Disease)",
      "score": 0.8,
      "description": "Autoimmune disease causing IgA deposits in the kidneys.",
      "overview": "Most common cause of kidney disease worldwide, often presenting with hematuria.",
      "signs_symptoms": [
        "Hematuria",
        "Proteinuria",
        "Flank pain",
        "Lower back pain",
        "Fatigue",
        "Changes in urine color",
        "Edema",
        "High blood pressure"
      ],
      "clinical_significance": "Can progress to CKD and end-stage renal disease.",
      "causes": "Genetic predisposition, environmental triggers, dysregulation of IgA.",
      "related_disorders": [
        "Henoch-Sch\u00f6nlein Purpura",
        "Nephrotic Syndrome",
        "Glomerulonephritis",
        "FSGS"
      ],
      "diagnosis": "Urine analysis, blood tests, kidney biopsy.",
      "treatment": "ACE inhibitors, immunosuppressants, fish oil.",
      "clinical_trials": [
        "Study of Leflunomide in IgA Nephropathy",
        "Trial of Tocilizumab"
      ],
      "key_aspects": [
        "Control of blood pressure",
        "Immunosuppressive therapy",
        "Symptom management"
      ]
    }
  ]
}